Vivo Bio Tech share news, announcements and annual reports
NSE: VIVOBIOTBSE: 511509Pharmaceuticals & BiotechnologySmall Cap
Vivo Bio Tech Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 1994
Last close ₹13.87down ₹0.31 (2.19%)BSE ₹13.85
Share price at the NSE close on 28 Oct 2026. Previous close ₹14.18.
28 Oct: open ₹14.18, high ₹14.39, low ₹13.38
52-week range of BSE trades to 28 Oct 2026
₹12.20Low, 26 Oct 2026₹35.76High, 13 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹31 Cr3,302nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.33
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −3.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.60 crore of one-off items, the largest of them in the quarter to Mar 2026.
- −2.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 5.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.72
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 15,01869.0% delivered
Vivo Bio Tech disputes and clarifications
20 filed, newest first.
Oct 2026
13 Oct · Legal
Jan 2024
4 Jan · Legal
Exchange has sought clarification from Vivo Bio Tech Ltd on January 4, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
Apr 2023
11 Apr · Legal
Exchange has sought clarification from Vivo Bio Tech Ltd on April 10, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
Sep 2022
7 Sep · Legal
Exchange has sought clarification from Vivo Bio Tech Ltd on September 6, 2022 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Jun 2021
15 Jun · Legal
Exchange has sought clarification from Vivo Bio Tech Ltd on June 15, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
May 2021
Nov 2020
26 Nov · Legal
Exchange has sought clarification from Vivo Bio Tech Ltd on November 26, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Aug 2020
20 Aug · Legal
20 Aug · Legal
Exchange has sought clarification from Vivo Bio Tech Ltd on August 20, 2020, with reference to Movement in Price. The reply is awaited.
Apr 2020
13 Apr · Legal
Exchange has sought clarification from Vivo Bio Tech Ltd on April 13, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
May 2019
23 May · Legal
Exchange has sought clarification from Vivo Bio Tech Ltd on May 23, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
Dec 2018
19 Dec · Legal
Exchange has sought clarification from Vivo Bio Tech Ltd on December 19, 2018 with reference to significant movement in price, in order to ensure that investors have latest relevant ....